Preactivation of β‐catenin in osteoblasts improves the osteoanabolic effect of PTH in type 1 diabetic mice

Fracture risk in young and middle-aged adults with type 1 diabetes mellitus: A systematic review and meta-analysis

(2018) Eleanor P. Thong et al.   CLINICAL ENDOCRINOLOGY

Tratamiento de la osteoporosis

(2018) Xavier Nogués et al.   MEDICINA CLINICA

MANAGEMENT OF ENDOCRINE DISEASE: Novel anabolic treatments for osteoporosis

(2017) Ernesto Canalis   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Constitutive β-catenin activation in osteoblasts impairs terminal osteoblast differentiation and bone quality

(2017) Quanwei Bao et al.   EXPERIMENTAL CELL RESEARCH

Exploiting the WNT Signaling Pathway for Clinical Purposes

(2017) Mark L. Johnson et al.   Current Osteoporosis Reports

Skeletal Metabolism, Fracture Risk, and Fracture Outcomes in Type 1 and Type 2 Diabetes

(2016) Deborah E. Sellmeyer et al.   DIABETES

Adult-Onset Deletion of β-Catenin in10kbDmp1-Expressing Cells Prevents Intermittent PTH-Induced Bone Gain

(2016) Rajendra Kedlaya et al.   ENDOCRINOLOGY

PTHrP-Derived Peptides Restore Bone Mass and Strength in Diabetic Mice: Additive Effect of Mechanical Loading

(2016) Marta Maycas et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Increased levels of Dickkopf-1 are indicative of Wnt/β-catenin downregulation and lower osteoblast signaling in children and adolescents with type 1 diabetes mellitus, contributing to lower bone mineral density

(2016) C. Tsentidis et al.   OSTEOPOROSIS INTERNATIONAL

Effects of Type 1 Diabetes on Osteoblasts, Osteocytes, and Osteoclasts

(2016) Evangelia Kalaitzoglou et al.   Current Osteoporosis Reports

Optimizing tamoxifen-inducible Cre/loxp system to reduce tamoxifen effect on bone turnover in long bones of young mice

(2015) Zhendong A. Zhong et al.   BONE

Parathyroid hormone: anabolic and catabolic actions on the skeleton

(2015) Barbara C Silva et al.   CURRENT OPINION IN PHARMACOLOGY

Adverse Effects of Osteocytic Constitutive Activation of ß-Catenin on Bone Strength and Bone Growth

(2015) Sixu Chen et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Bisphosphonate treatment of type I diabetic mice prevents early bone loss but accentuates suppression of bone formation

(2015) Lindsay M. Coe et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Diabetes and Its Effect on Bone and Fracture Healing

(2015) Hongli Jiao et al.   Current Osteoporosis Reports

Effects of high glucose and high insulin concentrations on osteoblast function in vitro

(2014) Juliana S. Cunha et al.   CELL AND TISSUE RESEARCH

Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts

(2014) Aruna Kode et al.   NATURE

Diabetic Osteopenia by Decreased β-Catenin Signaling Is Partly Induced by Epigenetic Derepression of sFRP-4 Gene

(2014) Kiyoshi Mori et al.   PLoS One

Oxidative Stress and Bone Resorption Interplay as a Possible Trigger for Postmenopausal Osteoporosis

(2014) Carlo Cervellati et al.   Biomed Research International

Chronic low dose tumor necrosis factor-α (TNF) suppresses early bone accrual in young mice by inhibiting osteoblasts without affecting osteoclasts

(2013) L.C. Gilbert et al.   BONE

Disruption of LRP6 in osteoblasts blunts the bone anabolic activity of PTH

(2013) Changjun Li et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Bone Metabolic Abnormalities Associated with Well-Controlled Type 1 Diabetes (IDDM) in Young Adult Women: A Disease Complication Often Ignored or Neglected

(2013) Priscilla G Massé et al.   JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION

Inducible control of gene expression with destabilized Cre

(2013) Richard Sando et al.   NATURE METHODS

Key role for the transcriptional factor, osterix, in spine development

(2013) SiXu Chen et al.   Spine Journal

Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee

(2012) David W Dempster et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Role of fibroblast growth factor 2 and wnt signaling in anabolic effects of parathyroid hormone on bone formation

(2012) Yurong Fei et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Estrogen-related receptor α regulates osteoblast differentiation via Wnt/β-catenin signaling

(2012) Kathryn L Auld et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Amelioration of type I diabetes-induced osteoporosis by parathyroid hormone is associated with improved osteoblast survival

(2011) Katherine J. Motyl et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Parathyroid hormone regulates osteoblast differentiation in a Wnt/β-catenin-dependent manner

(2011) Ye Tian et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Guidelines for assessment of bone microstructure in rodents using micro-computed tomography

(2010) Mary L Bouxsein et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Hyperglycemia Impairs Skeletogenesis from Embryonic Stem Cells by Affecting Osteoblast and Osteoclast Differentiation

(2010) Anke Dienelt et al.   STEM CELLS AND DEVELOPMENT

Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts

(2009) Nobuhiro Kamiya et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Role of Smad3, acting independently of transforming growth factor-β, in the early induction of Wnt-β-catenin signaling by parathyroid hormone in mouse osteoblastic cells

(2009) Yoshifumi Inoue et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts

(2008) Robert L. Jilka et al.   BONE

Differentiation and Proliferation of Periosteal Osteoblast Progenitors Are Differentially Regulated by Estrogens and Intermittent Parathyroid Hormone Administration

(2008) Mami Ogita et al.   ENDOCRINOLOGY

The cell biology of parathyroid hormone in osteoblasts

(2008) Stavroula Kousteni et al.   Current Osteoporosis Reports